Related Experiment Video
Updated: Aug 4, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Association of the Systemic Immune-Inflammation Index with Outcomes in Acute Coronary Syndrome Patients with Chronic
Sanling Shi1, Shuting Kong1, Weicheng Ni1
1Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, People's Republic of China.
Insights
The systemic immune-inflammation index (SII) predicts adverse cardiovascular outcomes in patients with acute coronary syndrome and chronic kidney disease. An elevated SII indicates a higher risk of major adverse cardiovascular events.
Area of Science:
- Cardiology
- Nephrology
- Immunology
Background:
- The systemic immune-inflammation index (SII) is a novel marker reflecting immune and inflammatory status.
- SII has been linked to poor prognosis in cardiovascular diseases.
Purpose of the Study:
- To investigate the association between SII and major adverse cardiovascular events (MACEs) in patients with acute coronary syndrome (ACS) and chronic kidney disease (CKD).
Main Methods:
- 744 patients with ACS and CKD were categorized into high and low SII groups.
- Follow-up for MACEs (cardiovascular death, myocardial infarction, stroke) over a median of 2.5 years.
- Statistical analyses included ROC curve, Kaplan-Meier, and Cox regression.
Main Results:
- An SII cutoff of 1159.84×10^9/L best predicted MACEs.
- High SII group had significantly higher MACE rates (38.8% vs 12.8%) and risk.
- Elevated SII was an independent predictor of MACEs (aHR: 1.865, 95% CI: 1.197-2.907).
Conclusions:
- Elevated SII is associated with adverse cardiovascular outcomes in ACS patients with CKD.
- SII may serve as a valuable prognostic predictor in this patient population.
- Further research is warranted to validate these findings.
Background:
The systemic immune-inflammation index (SII; neutrophil × platelet/lymphocyte) is a novel marker for immune and inflammatory status and is associated with adverse prognosis in cardiovascular disease.
Methods:
In total, 744 patients diagnosed with acute coronary syndrome (ACS) and chronic kidney disease (CKD) were included in our study, received standard therapies, and were followed up. Patients were divided into high and low SII groups according to the baseline SII. The primary endpoint was major cardiovascular events (MACEs), defined as cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke.
Results:
During a median follow-up of 2.5 years, a total of 185 (24.9%) MACEs were recorded. Analysis of the ROC curve revealed that the best cutoff value of SII was 1159.84×109/L for predicting MACEs. The Kaplan-Meier analysis showed that those patients in the low SII group had higher survival rates than those in the high SII group (p < 0.001). Compared to those in the low SII group, patients in the high SII group were at significantly higher risk of MACEs (134 (38.8%) vs 51 (12.8%), p < 0.001). Univariate and multivariable Cox regression analyses revealed that a high SII level was independently associated with MACEs in ACS patients with CKD (adjusted hazard ratio [HR]: 1.865, 95% confidence interval [CI]: 1.197-2.907, p = 0.006).
Conclusion:
The present study showed that an elevated SII is associated with adverse cardiovascular outcomes in ACS with CKD patients, suggesting that SII may be a valuable predictor of poor prognosis in ACS with CKD patients. Further studies are needed to confirm our findings.
More Related Videos
07:03Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury
Published on: February 15, 2022
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury I: Introduction
Chronic Kidney Disease III: Interprofessional Care